Mind the Byte
Mind the Byte helps pharmaceutical, biotech and academic research teams discover and optimize drug candidates using computational methods. The company offers a cloud-based, pay-per-use SaaS platform and consultancy that applies high-performance computing, Big Data analytics, and machine learning to virtual screening, target profiling, docking and drug repurposing workflows. Key technologies include AWS-hosted cloud computing, HPC, virtual screening pipelines, MtBDock and SmartDock docking protocols, and ML models trained on PDB interactions. The company targets early-stage drug discovery teams seeking scalable computational resources and chemistry-biology integration.
Mind the Byte
Mind the Byte helps pharmaceutical, biotech and academic research teams discover and optimize drug candidates using computational methods. The company offers a cloud-based, pay-per-use SaaS platform and consultancy that applies high-performance computing, Big Data analytics, and machine learning to virtual screening, target profiling, docking and drug repurposing workflows. Key technologies include AWS-hosted cloud computing, HPC, virtual screening pipelines, MtBDock and SmartDock docking protocols, and ML models trained on PDB interactions. The company targets early-stage drug discovery teams seeking scalable computational resources and chemistry-biology integration.
TL;DR
Founded: 2011
Headquarters: Barcelona, Spain
Product: Cloud-based, pay-per-use SaaS platform and consultancy for computational drug discovery
Tech focus: Virtual screening, docking, ML models for protein-ligand prediction
Funding (reported): Crowdfunding and public grants; total reported ≈ USD 840,696
Company Overview
Problem Domain
Computational drug discovery (virtual screening, molecular modelling, drug repurposing, target profiling).
Founded
2011
Industry
Biotechnology
Tech Stack
Funding Track Record
Equity crowdfunding round reported on Oct 22, 2015
ENISA listed among investors / financers
ICF Capital listed among investors
Investor Signal
“Crowdcube, ENISA, ICF Capital”